INSURANCE: Creates the PACE Task Force to prioritize access, care, and education on GLP-1 medications

HCR 120 establishes the PACE Task Force to study GLP-1 medications, which are drugs used for diabetes and weight loss that have seen a massive increase in demand and cost in Louisiana. This concurrent resolution directs the task force to investigate how these drugs affect insurance premiums, accessibility for different income groups, and the long-term financial impact on both public and private insurers. The group will consist of representatives from state agencies, health plans, and medical providers, who will meet to analyze pricing differences between diabetes and weight loss uses before submitting their findings to the legislature by February 2027.